Inhibitors of proteasomal activity for stimulating bone and hair growth
First Claim
1. A method to enhance bone formation or to treat pathological dental conditions or to treat degenerative joint conditions in a vertebrate animal, which method comprises administering to a vertebrate subject in need of such treatment an effective amount of a compound that inhibits the activity of NF-κ
- B or that inhibits proteasomal activity or that inhibits production of proteasome proteins wherein the compound does not inhibit the isoprenoid pathway.
1 Assignment
0 Petitions
Accused Products
Abstract
Compounds that inhibit the activity of NF-κB or inhibit the activity of the proteasome or both promote bone formation and hair growth and are thus useful in treating osteoporosis, bone fracture or deficiency, primary or secondary hyperparathyroidism, periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery, post-prosthetic joint surgery, and post-dental implantation; they also stimulate the production of hair follicles and are thus useful in stimulating hair growth, including hair density, in subject where this is desirable.
-
Citations
44 Claims
-
1. A method to enhance bone formation or to treat pathological dental conditions or to treat degenerative joint conditions in a vertebrate animal, which method comprises administering to a vertebrate subject in need of such treatment an effective amount of a compound that inhibits the activity of NF-κ
- B or that inhibits proteasomal activity or that inhibits production of proteasome proteins wherein the compound does not inhibit the isoprenoid pathway.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26, 27, 28, 30, 31, 32, 33, 34, 35, 36, 37, 38, 40, 41, 42)
-
25. A method to treat a mammalian subject for a condition benefited by stimulating hair growth which method comprises administering to said mammalian subject in need of such treatment an effective amount of a compound that inhibits the activity of NF-κ
- B or that inhibits proteasomal activity or that inhibits production of these proteins.
-
29. A pharmaceutical composition for treating bone disorders, dental pathological conditions or degenerative joint conditions, which composition comprises a compound that inhibits the activity of NF-κ
- B or that inhibits proteasomal activity or that inhibits production of these proteins, in the compound does not inhibit the isoprenoid pathway.
-
39. A pharmaceutical composition for treating a condition benefited by stimulating hair growth, which composition comprises a compound that inhibits the activity of NF-κ
- B or that inhibits proteasomal activity or that inhibits production of these proteins.
-
43. A method to identify a compound which enhances bone growth or stimulates hair growth, which method comprises subjecting said compound to an assay for determining its ability to inhibit NF-κ
- B activity, whereby a compound which inhibits the activity of NF-κ
B is identified as a compound which enhances bone growth or stimulates hair growth;
or subjecting said compound to an assay for determining its ability to inhibit the production of NF-κ
B, whereby a compound which inhibits the production of NF-κ
B is identified as a compound which enhances bone growth or stimulates hair growth;
or subjecting a candidate compound to an assay to assess its ability to inhibit proteasomal activity, whereby a compound which inhibits proteasomal activity is identified as a compound that enhances bone growth or stimulates hair growth;
or subjecting a candidate compound to an assay to assess its ability to inhibit the production of enzymes with proteasomal activity, whereby a compound which inhibits the production of enzymes with proteasomal activity is identified as a compound that enhances bone growth or stimulates hair growth. - View Dependent Claims (44)
- B activity, whereby a compound which inhibits the activity of NF-κ
Specification